Chronic Oral Treatment with 13-cis-Retinoic Acid (Isotretinoin) or all-trans-Retinoic Acid Does Not Alter Depression-Like Behaviors in Rats

Oral treatment with the anti-acne drug Accutane (isotretinoin, 13-cis-retinoic acid) has been associated with suicide ideation and depression. Here, depression-like behaviors (i.e., behavioral despair and anhedonia) were quantified in adult Sprague-Dawley rats gavaged daily beginning at postnatal da...

Full description

Saved in:
Bibliographic Details
Published inToxicological sciences Vol. 87; no. 2; pp. 451 - 459
Main Authors Ferguson, Sherry A., Cisneros, F. Javier, Gough, B., Hanig, Joseph P., Berry, Kimberly J.
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 01.10.2005
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Oral treatment with the anti-acne drug Accutane (isotretinoin, 13-cis-retinoic acid) has been associated with suicide ideation and depression. Here, depression-like behaviors (i.e., behavioral despair and anhedonia) were quantified in adult Sprague-Dawley rats gavaged daily beginning at postnatal day (PND) 82 with 13-cis-RA (7.5 or 22.5 mg/kg) or all-trans-retinoic acid (10 or 15 mg/kg ). Tested at PND 130–131 in the Forced Swim Test, 7.5 mg/kg 13-cis-RA marginally decreased immobility and slightly increased climb/struggle durations whereas neither all-trans-retinoic acid group differed from controls. Voluntary saccharin solution (0.03%) intake at PND 102–104 and PND 151–153 was not different from controls in any treated group, although all RA-treated groups had lower intakes. Swim speed in a water maze at PND 180 was similar across groups, indicating no RA-induced differences in physical ability. Open field activity was mildly decreased at PND 91 in 7.5 mg/kg–treated males only, but it was within the control range at PND 119, 147, and 175. Thus, at serum levels similar to those in humans receiving the drug, chronic 13-cis-RA treatment did not severely affect depression-like behaviors in rats. These data do not substantiate the hypothesis of 13-cis-RA-induced depression.
Bibliography:istex:112336C0AC120A43550AD73A4F652ED8F7CCB6A4
local:kfi262
ark:/67375/HXZ-9MWTCD41-T
1To whom correspondence should be addressed at Division of Neurotoxicology, NCTR/FDA, 3900 NCTR Road, Jefferson, AR 72079. Fax: 870–543–7745. E-mail: sferguson@nctr.fda.gov.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1096-6080
1096-0929
DOI:10.1093/toxsci/kfi262